Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALT Altimmune	$3.54 +0.3%	$4.44	$2.90 ▼ $11.16	$312.43M	-0.01	2.89 million shs	2.83 million shs
COLL Collegium Pharmaceutical	$39.11 -1.0%	$32.42	$23.23 ▼ $42.29	$1.23B	0.68	425,737 shs	447,830 shs
CVAC CureVac	$5.44 +0.4%	$5.44	$2.37 ▼ $5.72	$1.22B	2.53	694,622 shs	353,942 shs
TLRY Tilray Brands	$1.15 +3.6%	$0.66	$0.35 ▼ $1.95	$1.27B	1.85	76.75 million shs	51.16 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALT Altimmune	0.00%	-2.48%	-13.87%	-38.00%	-48.47%
COLL Collegium Pharmaceutical	0.00%	+3.63%	+21.80%	+35.52%	+9.80%
CVAC CureVac	0.00%	-0.73%	0.00%	+33.01%	+63.86%
TLRY Tilray Brands	0.00%	+11.65%	+63.63%	+159.95%	-39.15%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALT Altimmune	3.2544 of 5 stars	4.3	3.0	0.0	1.9	1.7	0.6
COLL Collegium Pharmaceutical	2.3564 of 5 stars	1.5	0.0	3.0	3.4	0.8	1.3
CVAC CureVac	4.6433 of 5 stars	4.1	5.0	4.9	1.6	0.0	1.3
TLRY Tilray Brands	2.4427 of 5 stars	3.1	1.0	0.0	3.2	1.7	1.3

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALT Altimmune	2.57	Moderate Buy	$17.40	391.53% Upside
COLL Collegium Pharmaceutical	3.00	Buy	$42.33	8.24% Upside
CVAC CureVac	2.20	Hold	$6.83	25.61% Upside
TLRY Tilray Brands	2.20	Hold	$1.92	66.67% Upside

Current Analyst Ratings Breakdown

Latest ALT, TLRY, CVAC, and COLL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	ALT Altimmune	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
8/13/2025	ALT Altimmune	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$26.00 ➝ $24.00
8/13/2025	ALT Altimmune	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$20.00 ➝ $18.00
8/11/2025	COLL Collegium Pharmaceutical	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$44.00
7/29/2025	TLRY Tilray Brands	Zelman & Associates Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral
7/10/2025	ALT Altimmune	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong Sell
7/10/2025	ALT Altimmune	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Market Outperform ➝ Market Outperform	$25.00 ➝ $15.00
6/27/2025	ALT Altimmune	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform ➝ Market Perform
6/27/2025	ALT Altimmune	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00
6/26/2025	CVAC CureVac	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Neutral	$12.00 ➝ $5.50
6/13/2025	CVAC CureVac	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$7.00 ➝ $5.00

(Data available from 8/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALT Altimmune	$20K	15,622.02	N/A	N/A	$1.74 per share	2.03
COLL Collegium Pharmaceutical	$631.45M	1.95	$12.34 per share	3.17	$7.10 per share	5.51
CVAC CureVac	$579.18M	2.11	$0.87 per share	6.23	$3.36 per share	1.62
TLRY Tilray Brands	$821.31M	1.54	$0.14 per share	7.96	$1.40 per share	0.82

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALT Altimmune	-$95.06M	-$1.18	0.00	N/A	N/A	-438,730.03%	-62.63%	-55.29%	11/11/2025 (Estimated)
COLL Collegium Pharmaceutical	$69.19M	$1.04	6.73	6.50	N/A	5.13%	97.28%	13.87%	11/6/2025 (Estimated)
CVAC CureVac	$175.50M	$0.96	5.67	N/A	N/A	38.21%	29.57%	25.41%	11/11/2025 (Estimated)
TLRY Tilray Brands	-$2.19B	-$2.31	0.00	N/A	N/A	-265.69%	-6.83%	-5.45%	10/9/2025 (Estimated)

Latest ALT, TLRY, CVAC, and COLL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/21/2025	Q2 2025	CVAC CureVac	-$0.15	-$0.30	-$0.15	-$0.30	$4.27 million	$1.41 million
8/12/2025	Q2 2025	ALT Altimmune	-$0.32	-$0.27	+$0.05	-$0.27	$0.00 million	$0.01 million
7/28/2025	Q4 2025	TLRY Tilray Brands	-$0.03	$0.02	+$0.05	-$1.30	$250.41 million	$224.54 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALT Altimmune	N/A	N/A	N/A	N/A	N/A
COLL Collegium Pharmaceutical	N/A	N/A	N/A	N/A	N/A
CVAC CureVac	N/A	N/A	N/A	N/A	N/A
TLRY Tilray Brands	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALT Altimmune	0.09	20.44	20.44
COLL Collegium Pharmaceutical	3.27	1.18	1.10
CVAC CureVac	0.05	6.17	7.64
TLRY Tilray Brands	0.20	2.46	1.49

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALT Altimmune	78.05%
COLL Collegium Pharmaceutical	N/A
CVAC CureVac	17.26%
TLRY Tilray Brands	9.35%

Insider Ownership

Company	Insider Ownership
ALT Altimmune	4.40%
COLL Collegium Pharmaceutical	2.51%
CVAC CureVac	N/A
TLRY Tilray Brands	0.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALT Altimmune	50	88.26 million	84.37 million	Optionable
COLL Collegium Pharmaceutical	210	31.50 million	30.71 million	Optionable
CVAC CureVac	880	224.34 million	N/A	Optionable
TLRY Tilray Brands	2,842	1.10 billion	1.09 billion	Optionable

ALT, TLRY, CVAC, and COLL Headlines

Recent News About These Companies

Tilray Brands (NASDAQ:TLRY) Trading Up 2.3% - What's Next?

August 23 at 4:46 PM | marketbeat.com

Tilray Brands, Inc. (NASDAQ:TLRY) Given Average Recommendation of "Hold" by Analysts

August 23 at 3:41 AM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Stock Price Up 3.3% - Here's What Happened

August 22 at 1:46 PM | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Trading Down 3.3% - Time to Sell?

August 21 at 3:37 PM | marketbeat.com

Tilray's High Hopes: The Catalyst Driving Cannabis Stocks

...

August 21 at 2:09 PM | marketbeat.com

Top Cannabis Stocks To Watch Today - August 20th

August 21 at 1:11 PM | marketbeat.com

Unleashing the Spirit of Adventure: Breckenridge Distillery Launches Mountain Shot, a Bold New Mushroom-Infused Elixir

August 21 at 7:00 AM | globenewswire.com

Tilray Brands (NASDAQ:TLRY) Trading Down 7.5% - Time to Sell?

August 20, 2025 | marketbeat.com

Cannabis Stocks To Follow Today - August 19th

August 20, 2025 | marketbeat.com

Tilray Shares Blazing: What's Behind the 55% Rally This Month?

...

August 20, 2025 | marketbeat.com

If You'd Invested $1,000 in Tilray Stock 5 Years Ago, Here's How Much You'd Have Today

August 20, 2025 | fool.com

Tilray Brands (NASDAQ:TLRY) Shares Up 9.2% - Time to Buy?

August 19, 2025 | marketbeat.com

Promising Cannabis Stocks To Add to Your Watchlist - August 18th

August 19, 2025 | marketbeat.com

Tilray Brands (NASDAQ:TLRY) Shares Gap Up - Here's Why

August 19, 2025 | marketbeat.com

Tilray Brands (NASDAQ TLRY) Rises Amid NASDAQ Composite Market Trends

August 19, 2025 | kalkinemedia.comK

Promising Cannabis Stocks To Add to Your Watchlist - August 17th

August 18, 2025 | marketbeat.com

National Bank of Canada FI Sells 763,247 Shares of Tilray Brands, Inc. $TLRY

August 18, 2025 | marketbeat.com

Tilray Brands (TLRY) Boosts Revenue Mix with New Cannabis, Wellness, and Beverage Products

August 17, 2025 | insidermonkey.com

Cannabis Stocks Worth Watching - August 16th

August 17, 2025 | marketbeat.com

Best Canadian Cannabis Stocks in 2025

August 17, 2025 | marijuanastocks.comM

Tilray Brands (NASDAQ:TLRY) Trading Down 7.2% - Here's What Happened

August 16, 2025 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ALT, TLRY, CVAC, and COLL Company Descriptions

Altimmune NASDAQ:ALT

$3.54 +0.01 (+0.28%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$3.54 0.00 (-0.14%)

As of 08/22/2025 07:59 PM Eastern

Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide, a GLP-1/glucagon dual receptor agonist that is in Phase 2 trial for the treatment of obesity and metabolic dysfunction-associated steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryland.

Collegium Pharmaceutical NASDAQ:COLL

$39.11 -0.41 (-1.04%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$39.12 +0.01 (+0.01%)

As of 08/22/2025 05:11 PM Eastern

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.

CureVac NASDAQ:CVAC

$5.44 +0.02 (+0.37%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$5.43 -0.01 (-0.18%)

As of 08/22/2025 05:32 PM Eastern

CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in Tübingen, Germany.

Tilray Brands NASDAQ:TLRY

$1.15 +0.04 (+3.60%)

Closing price 08/22/2025 04:00 PM Eastern

Extended Trading

$1.14 0.00 (-0.43%)

As of 08/22/2025 07:59 PM Eastern

Tilray, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc. is headquartered in Canada.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time